<DOC>
	<DOCNO>NCT00120380</DOCNO>
	<brief_summary>The purpose study test whether addition inhale iloprost safe effective patient idiopathic pulmonary arterial hypertension already treat endothelin receptor antagonist bosentan .</brief_summary>
	<brief_title>Combination Therapy Bosentan Aerosolized Iloprost Idiopathic Pulmonary Arterial Hypertension ( IPAH )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<criteria>IPAH &gt; 3 month treatment bosentan 6 minute walk distance 150 425 form pulmonary hypertension severe comorbidities cotreatment sildenafil investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>Idiopathic pulmonary arterial hypertension</keyword>
</DOC>